Alternatively, HDL-C and Apo A-I (the main protein component of HDL-C) inhibit cytokine- or glucose-induced apoptosis in β-cells and promote insulin secretion by means of the S1P signaling pathway (41), and the reduction in HDL-C in patients with NAFLD further promotes glucose metabolism disorders. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.